日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The value of Protein Phosphatase Methylesterase 1 in diagnosis, prognosis and immunoregulation: from pan-cancer analysis to breast cancer verification.

蛋白磷酸酶甲基酯酶 1 在诊断、预后和免疫调节中的价值:从泛癌分析到乳腺癌验证。

Wang Yiyang, Zhang Yue, Li Yongxiang, Ma Haotian, Zhao Jiawei, Ismtula Dilimulati, Guo Chenming

Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker.

综合泛癌分析和乳腺癌验证确定 BEND3 为潜在的预后和免疫生物标志物。

Gou Yuting, Li Yongxiang, Wang Yiyang, Ma Haotian, Li Haocong, Geni Reyima, Ismtula Dilimulati, Guo Chenming

Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer.

Bystin 是一种预后和免疫生物标志物:从泛癌分析到乳腺癌验证

Aimaiti Xiyidan, Wang Yiyang, Ismtula Dilimulati, Li Yongxiang, Ma Haotian, Wang Junyi, Elihamu Dilraba, Guo Chenming

CLIC6's role in cancer: from broad analysis to breast cancer validation

CLIC6在癌症中的作用:从广泛分析到乳腺癌验证

Wang, Junyi; Wang, Yiyang; Ma, Haotian; Li, Yongxiang; Hou, Jiayue; Li, Jiaqi; Ismtula, Dilimulati; Guo, Chenming

CORO1A: a pan-cancer prognosis, diagnostic and immune biomarker based on breast cancer validation

CORO1A:一种基于乳腺癌验证的泛癌预后、诊断和免疫生物标志物

Elihamu, Dilraba; Li, Yongxiang; Wang, Yiyang; Cui, Haiyan; Xing, Yiting; Peng, Haohao; Ismtula, Dilimulati; Guo, Chenming

Cytokine-induced apoptosis inhibitor 1: a comprehensive analysis of potential diagnostic, prognosis, and immune biomarkers in invasive breast cancer

细胞因子诱导的细胞凋亡抑制剂1:浸润性乳腺癌潜在诊断、预后和免疫生物标志物的综合分析

Luo, Zhiwen; Wang, Yiyang; Bi, Xiaojuan; Ismtula, Dilimulati; Wang, Haiyan; Guo, Chenming